Literature DB >> 9931075

Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension.

K P Makaritsis1, D E Handy, C Johns, B Kobilka, I Gavras, H Gavras.   

Abstract

Salt sensitivity is a common trait in patients with essential hypertension and seems to have both an inherited and an acquired component (eg, is influenced by aging and renal insufficiency). Experimental evidence suggests that salt loading induces hypertension via a neurogenic mechanism mediated by the alpha2-adrenergic receptors (alpha2-AR). To explore the alpha2-AR subtype involved in this mechanism, we studied 2 groups of mice genetically engineered to be deficient in one of the 3 alpha2-AR subtype genes (either alpha2B-AR +/- or alpha2C-AR -/- knockout mice) compared with their wild-type counterparts. The mice (n=10 to 14 in each group) were submitted to subtotal nephrectomy and given 1% saline as drinking water for up to 35 days. Blood pressure (BP) was monitored by tail-cuff readings and confirmed at the end point by direct intra-arterial BP recording. The alpha2B-AR-deficient mice had an attenuated BP response in this protocol (baseline 101.8+/-2.7 versus end point 109.9+/-2.8 mm Hg), whereas the BP of their wild-type counterparts went from a baseline 101.9+/-2.3 to an end point 141.4+/-7.1 mm Hg. The other 2 groups had BP increases of 44. 6+/-5.17 and 46.7+/-7.01 mm Hg, with no difference between the mice deficient in the alpha2C-AR gene subtype versus their wild-type counterparts. Body weight, renal remnant weight, and residual renal function were no different among groups. These data suggest that a full complement of alpha2B-AR genes is necessary to raise BP in response to dietary salt loading, whereas complete absence of the alpha2C-AR subtype does not preclude salt-induced BP elevation. It is unclear whether the mechanism(s) involved in this process are of central origin (inability to increase sympathetic outflow), vascular origin (inability to vasoconstrict), or renal origin (inability to retain excess salt and fluid).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931075     DOI: 10.1161/01.hyp.33.1.14

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  The role of the nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.

Authors:  Inna Belfer; Beata Buzas; Heather Hipp; Gabriel Phillips; Julie Taubman; Ilona Lorincz; Catherine Evans; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  J Hum Genet       Date:  2004-12-08       Impact factor: 3.172

3.  JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain.

Authors:  M D Tricklebank
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

4.  Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.

Authors:  K Gyires; Z S Zádori; N Shujaa; M Al-Khrasani; B Pap; M M Mózes; P Mátyus
Journal:  Inflammopharmacology       Date:  2009-06-13       Impact factor: 4.473

5.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  High level of alpha2-adrenoceptor in rat foetal liver and placenta is due to alpha2B-subtype expression in haematopoietic cells of the erythrocyte lineage.

Authors:  D Cussac; S Schaak; C Denis; C Flordellis; D Calise; H Paris
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 7.  Mouse models of blood pressure regulation and hypertension.

Authors:  F Sugiyama; K Yagami ; B Paigen
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

8.  Subcellular distribution of α2-adrenoceptor subtypes in the rodent kidney.

Authors:  Takaomi Shimokawa; Toshitaka Nakagawa; Kohei Hayashi; Masayo Yamagata; Kozo Yoneda
Journal:  Cell Tissue Res       Date:  2021-11-27       Impact factor: 5.249

9.  Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited.

Authors:  Torill Berg; Sven Ivar Walaas; Bjørg Åse Roberg; Trang Thi Huynh; Jørgen Jensen
Journal:  Front Neurol       Date:  2012-11-08       Impact factor: 4.003

10.  The insertion/deletion variation in the alpha2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes.

Authors:  Amir Snapir; Mika Scheinin; Leif C Groop; Marju Orho-Melander
Journal:  Cardiovasc Diabetol       Date:  2003-11-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.